International collaboration between Japan and Chile to improve detection rates in colorectal cancer screening

Cancer

Volumn 122, Issue 1, 2016, Pages 71-77

  Okada, Takuya ^a   Tanaka, Koji ^a   Kawachi, Hiroshi ^a   Ito, Takashi ^a   Nishikage, Tetsuro ^a   Odagaki, Tomoyuki ^a   Zárate, Alejandro J ^b   Kronberg, Udo ^b   Lõpez Köstner, Francisco ^b   Karelovic, Stanko ^c   Flores, Sergio ^d   Estela, Ricardo ^e   Tsubaki, Masahiro ^a   Uetake, Hiroyuki ^a   Eishi, Yoshinobu ^a   Kawano, Tatsuyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b CLÍNICA LAS CONDES   (Chile)

^c Hospital Clínico Dr Lautaro Navarro Avaria   (Chile)

^d Hospital Eduardo Pereira   (Chile)

^e HOSPITAL SAN BORJA ARRIARÁN   (Chile)

Author keywords

adenoma detection rate; colonoscopy; colorectal cancer; diagnostic techniques and procedures; international cooperation; screening; training programs

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CHILE; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; INTERNATIONAL COOPERATION; JAPAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MUCOSAL CANCER; PRIORITY JOURNAL; COLORECTAL NEOPLASMS; COOPERATION; EARLY CANCER DIAGNOSIS; HEALTH; MASS SCREENING; PROCEDURES;

CHILE; COLONOSCOPY; COLORECTAL NEOPLASMS; COOPERATIVE BEHAVIOR; EARLY DETECTION OF CANCER; FEMALE; GLOBAL HEALTH; HUMANS; INTERNATIONAL COOPERATION; JAPAN; MALE; MASS SCREENING; MIDDLE AGED;

EID: 84945157385     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29715     Document Type: Article

References (36)

1. Ferlay J, Soerjomataram I, Dikshit R, et al., Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015; 136: E359-E386.
2. Zarate AJ, Alonso FT, Garmendia ML, Lopez-Kostner F,. Increasing crude and adjusted mortality rates for colorectal cancer in a developing South American country. Colorectal Dis. 2013; 15: 47-51.
3. Mandel JS, Church TR, Ederer F, Bond JH,. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst. 1999; 91: 434-437.
4. Hardcastle JD, Chamberlain JO, Robinson MH, et al., Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996; 348: 1472-1477.
5. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O,. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996; 348: 1467-1471.
6. Nakajima M, Saito H, Soma Y, Sobue T, Tanaka M, Munakata A,. Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: a case-control study. Br J Cancer. 2003; 89: 23-28.
7. Winawer SJ, Zauber AG, Ho MN, et al., Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993; 329: 1977-1981.
8. Citarda F, Tomaselli G, Capocaccia R, Barcherini S, Crespi M,; Italian Multicentre Study Group. Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut. 2001; 48: 812-815.
9. Zauber AG, Winawer SJ, O'Brien MJ, et al., Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012; 366: 687-696.
10. van Rossum LG, van Rijn AF, Laheij RJ, et al., Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008; 135: 82-90.
11. Telford JJ, Levy AR, Sambrook JC, Zou D, Enns RA,. The cost-effectiveness of screening for colorectal cancer. CMAJ. 2010; 182: 1307-1313.
12. Lopez-Kostner F, Kronberg U, Zarate AJ, et al., A screening program for colorectal cancer in Chilean subjects aged fifty years or more [in Spanish]. Rev Med Chil. 2012; 140: 281-286.
13. Imperiali G, Minoli G, Meucci GM, et al., Effectiveness of a continuous quality improvement program on colonoscopy practice. Endoscopy. 2007; 39: 314-318.
14. Kaminski MF, Regula J, Kraszewska E, et al., Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010; 362: 1795-1803.
15. Corley DA, Jensen CD, Marks AR, et al., Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014; 370: 1298-1306.
16. Rubeca T, Rapi S, Confortini M, et al., Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB Gold and OC Sensor assays in a consecutive prospective screening series. Int J Biol Markers. 2006; 21: 157-161.
17. Castiglione G, Grazzini G, Miccinesi G, et al., Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen. 2002; 9: 99-103.
18. Fenocchi E, Martinez L, Tolve J, et al., Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer Prev. 2006; 15: 384-390.
19. Sobin LH, Gospodarowicz MK, Wittekind C,. TNM Classification of Malignant Tumours. 7th ed. New York: John Wiley & Sons Inc; 2009.
20. Tanaka S, Terasaki M, Kanao H, Oka S, Chayama K,. Current status and future perspectives of endoscopic submucosal dissection for colorectal tumors. Dig Endosc. 2012; 24 (suppl 1): 73-79.
21. Lai EJ, Calderwood AH, Doros G, Fix OK, Jacobson BC,. The Boston bowel preparation scale: a valid and reliable instrument for colonoscopy-oriented research. Gastrointest Endosc. 2009; 69 (3 pt 2): 620-625.
22. Fu WP, Kam MH, Ling WM, Ong SF, Suzannah N, Eu KW,. Screening for colorectal cancer using a quantitative immunochemical faecal occult blood test: a feasibility study in an Asian population. Tech Coloproctol. 2009; 13: 225-230.
23. van Roon AH, Wilschut JA, Hol L, et al., Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clin Gastroenterol Hepatol. 2011; 9: 333-339.
24. McNamara D, Qasim A, Lee N, Condon C, O'Morain C,. Round 1 of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices. Ir J Med Sci. 2011; 180: 549-552.
25. Mandel JS, Church TR, Bond JH, et al., The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000; 343: 1603-1607.
26. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003; 58 (suppl 6): S3-S43.
27. Heresbach D, Barrioz T, Lapalus MG, et al., Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy. 2008; 40: 284-290.
28. Soetikno RM, Kaltenbach T, Rouse RV, et al., Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA. 2008; 299: 1027-1035.
29. Moss A, Bourke MJ, Williams SJ, et al., Endoscopic mucosal resection outcomes and prediction of submucosal cancer from advanced colonic mucosal neoplasia. Gastroenterology. 2011; 140: 1908-1918.
30. Rex DK, Cummings OW, Helper DJ, et al., 5-year incidence of adenomas after negative colonoscopy in asymptomatic average-risk persons. Gastroenterology. 1996; 111: 1178-1181.
31. George SM, Makinen MJ, Jernvall P, Makela J, Vihko P, Karttunen TJ,. Classification of advanced colorectal carcinomas by tumor edge morphology: evidence for different pathogenesis and significance of polypoid and nonpolypoid tumors. Cancer. 2000; 89: 1901-1909.
32. Mitooka H, Fujimori T, Maeda S, Nagasako K,. Minute flat depressed neoplastic lesions of the colon detected by contrast chromoscopy using an indigo carmine capsule. Gastrointest Endosc. 1995; 41: 453-459.
33. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL,. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med. 2006; 355: 2533-2541.
34. Simmons DT, Harewood GC, Baron TH, et al., Impact of endoscopist withdrawal speed on polyp yield: implications for optimal colonoscopy withdrawal time. Aliment Pharmacol Ther. 2006; 24: 965-971.
35. Barclay RL, Vicari JJ, Greenlaw RL,. Effect of a time-dependent colonoscopic withdrawal protocol on adenoma detection during screening colonoscopy. Clin Gastroenterol Hepatol. 2008; 6: 1091-1098.
36. Rex DK,. Colonoscopic withdrawal technique is associated with adenoma miss rates. Gastrointest Endosc. 2000; 51: 33-36.